Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Somalogic Inc (NQ: SLGC )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Somalogic Inc

< Previous 1 2 Next >
SomaLogic Reports First Quarter 2023 Financial Results
From SomaLogic
Via GlobeNewswire
SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership
SomaLogic to deliver 7,000-plex SomaScan® Platform to researchers in attractive Chinese proteomics market 
From SomaLogic
Via GlobeNewswire
SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers
From SomaLogic
Via GlobeNewswire
SomaLogic, Inc. (SLGC) Shareholder Investigation: Robbins LLP is Investigating SomaLogic, Inc. on behalf of Shareholders
From Robbins LLP
Via Business Wire
SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023
From SomaLogic
Via GlobeNewswire
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution
From SomaLogic
Via GlobeNewswire
Oxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples
From SomaLogic
Via GlobeNewswire
SomaLogic to Announce Fourth Quarter and Full Year 2022 Financial Results
From SomaLogic
Via GlobeNewswire
SomaLogic announces Certified Site expansion through world-class multiomics initiative with Group 42 Healthcare
From SomaLogic, Inc
Via GlobeNewswire
SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates
Presenting at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 11:15 a.m. Pacific Time 
From SomaLogic, Inc
Via GlobeNewswire
SomaLogic to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
FonesLife offers the 7,000-plex SomaScan® Platform as Japan’s first SomaLogic™ Certified Site
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
Proteomics labs worldwide can now access SomaLogic’s industry-leading 7,000-plex SomaScan® Assay with the Certified Site program
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
Study finds proteomic risk scores for cardiovascular disease from SomaSignal® Cardio DM™ tests could support physicians in managing patient outcomes
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic Reports Third Quarter 2022 Financial Results
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic Teams with Molecular Genomics to Bring the 7,000-Plex SomaScan® Platform to Asia
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic presents new research at American Heart Association Scientific Sessions that illustrates the power of proteomics in addressing cardiovascular disease
SomaLogic and prominent research partners will lead five sessions about CVD and other leading causes of death 
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic’s 7K SomaScan® Platform receives high marks in independent technical assessment by researchers at the National Institutes of Health
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic to Announce Third Quarter 2022 Financial Results
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic Announces the Appointment of Biotech Veteran Troy Cox as Executive Chairman of the Board of Directors
From SomaLogic Operating Company, Inc.
Via GlobeNewswire
SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
From SomaLogic, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.